Click here for the preregistration roster.
Click here for a pdf of the Final Program.
EDUCATIONAL SESSION SCHEDULE
Friday, June 16, 2017
8:00 a.m. - 8:50 a.m.
Joshua D. Schiffman, MD, Associate Professor of Pediatrics, University of Utah; Adjunct Associate Professor, Department of Oncological Sciences, Division of Hematology/Oncology, Primary Children’s Medical Center; Medical Director, High Risk Pediatric Cancer Clinic, Huntsman Cancer Institute
9:00 a.m. – 9:50 a.m.
Victoria M. Pratt, PhD, FACMG, Director of Pharmacogenetics and Molecular Genetics Laboratories, Indiana University School of Medicine
10:35 a.m. – 11:25 a.m.
Stephen Moore, MBA, PhD, FACMG, Director, Cytogenetics and Molecular, Knight Diagnostic Laboratories; Assistant Professor, Oregon Health and Science University
11:25 a.m. – 12:15 p.m.
Cynthia Casson Morton, PhD, FFACMG, Director of Cytogenetics, William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital; Professor of Pathology, Harvard Medical School
1:15 p.m. – 1:45 p.m.
Martin, Margaret & Sam Israel, Fragile X Syndrome Family
1:45 p.m. – 2:25 p.m.
Denise I. Quigley, PhD, FACMGG, Medical Director, Cytogenetics, ARUP Laboratories
2:25 p.m. - 3:05 p.m.
Nathan D. Montgomery, MD, PhD, Molecular Genetic Pathology Fellow, The University of North Carolina School of Medicine
3:05 p.m. - 3:45 p.m.
Eli Williams, PhD, FACMG, Director of Cytogenetics, Co-Scientific Director of Clinical Genomics, University of Virginia
4:20 p.m. – 5:10 p.m.
Emily G. Farrow, PhD, CGC, Director of Laboratory Operations, Center for Pediatric Genomic Medicine; Assistant Professor, Children’s Mercy Hospitals and Clinics
5:10 p.m. – 6:00 p.m.
Genetics & Genomics of Fanconi Anemia
Lisa Dyer, PhD, Co-Director of Cytogenetics, Cincinnati Children’s Hospital Medical Center
Saturday, June 17, 2017
9:10 a.m. – 10:00 a.m.
Rhett P. Ketterling, MD, Co-Director, Laboratory; Professor of Laboratory Medicine and Pathology, Mayo Clinic
10:30 a.m. – 11:20 a.m.
Philip D. Cotter, PhD, FACMGG, FFSc(RCPA), Laboratory Director, ResearchDx, Inc.
11:20 a.m. – 12:10 p.m.
Cytogenetic Studies Supporting the Development of New Immunotherapy for B-cell Acute Lymphoblastic Leukemia
Vania Aikawa, MD, Laboratory Supervisor, University of Pennsylvania
12:10 p.m. - 12:25 p.m.
Student Research Award Winner Abstract Presentation: Comparison of Whole Genom Sequencing & Conventional Molecular Techniques for Genotyping Bacterial Isolates Causing Bacteremia in Cancer Patients
Wenrui Ye, Graduate Student, University of Texas MD Anderson Cancer Center
1:45 p.m. – 2:30 p.m.
1A. Strategic Genetic Testing Algorithms for Diagnosis
Yoshiko Mito, PhD, FACMG, Associate Director of Cytogenetics and Molecular Pathology; Assistant Professor of Pathology and Immunology, Washington University School of Medicine
Jennifer Sanmann, PhD, FACMG, Director; Assistant Professor, University of Nebraska Medical Center, Human Genetics Laboratory
2:30 p.m. – 3:45 p.m.
Roundtable Discussions: Expanding Knowledge through Dialogue (no handouts)
2:30 p.m. - 3:10 p.m.
2A. Molecular Roundtable Discussions
2B. Cytogenetic Roundtable Discussions
3:10 p.m. - 3:45 p.m.
3A. Education & Career Development Rountable Discussions
3B. Compliance & Quality Roundtable Discussions
4:00 p.m. – 5:30 p.m.
4A. Molecular/Biochemical Platform Presentations
Michael Evenson, CG(ASCP)CM, Cytogenetic Technologist, Washington University School of Medicine, et al.
Allison Cason, Biochemical Lab Technologist, Greenwood Genetics Center, et al.
Shelley Ordorica, MLT, Specialty Technologist, Children's Hospital of Eastern Ontario, et al.
4B. Cytogenetics Platform Presentations
C1 Comparison of Interleukin Stimulants on Cultured Plasma Cells to Increase the Detection of Cytogenetic Abnormalities
Natalie AaronsCooke, CG(ASCP), Clinical Laboratory Technician II, NeoGenomics, et al.
C2 Validation of a 17 Probe Fluorescence In-Situ Hybridization (FISH) Panel for Detection of T-Lymphoblastic Leukemia/Lymphoma (T-ALL) Abnormalities on Paraffin-Embedded Specimens
Ivy M. Luoma, CG(ASCP), Development Technologist, Mayo Clinic, et al.
C3 Dual-Color, Break-Apart FISH Assay For PRKACA Rearrangements in Fibrolamellar Carcinoma
Christopher A. Sattler, CG(ASCP), Development Technologist, Mayo Clinic, et al.
C4 Implementation of Intellifish Hybridization Solution Improves Chronic Lymphocytic Leukemia (CLL) FISH
Hong Xiao, PhD, Senior Technologist, University of Michigan, et al.
C5 Partial Trisomy 18 Mosaicism Detected Prenatally: A Cautionary Case Describing the Importance of Follow-Up Testing in CVS Samples
Matthew Noll, CG(ASCP), Technologist, Laboratory Corporation of America® Holdings, Center for Molecular Biology and Pathology, Department of Cytogenetics (LabCorp), et al.
C6 Hypodiploidy vs. Hyperdiploidy in B-Cell Acute Lymphoblastic Leukemia
Sally Kochmar, MS, CG(ASCP), Laboratory Manager, Magee-Womens Hospital Medical Genetics and Genomics Labs, University of Pittsburgh Medical Center, et al.